Prognosis and treatment of Waldenström’s macroglobulinemia
- 30 April 2010
- journal article
- review article
- Published by Elsevier BV in Transfusion and Apheresis Science
- Vol. 42 (2), 193-197
- https://doi.org/10.1016/j.transci.2010.01.017
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenström Macroglobulinemia Treated With Nucleoside AnalogsJournal of Clinical Oncology, 2009
- Update on Treatment Recommendations From the Fourth International Workshop on Waldenström's MacroglobulinemiaJournal of Clinical Oncology, 2009
- Update on therapeutic options in Waldenström macroglobulinemiaEuropean Journal of Haematology, 2008
- The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimensHaematologica, 2008
- Hyperviscosity-Related Retinopathy in Waldenström MacroglobulinemiaAmerican Journal of Ophthalmology, 2006
- Gene-expression profiling of Waldenström macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myelomaBlood, 2006
- Monoclonal Gammopathy of Undetermined Significance, Waldenström Macroglobulinemia, AL Amyloidosis, and Related Plasma Cell Disorders: Diagnosis and TreatmentMayo Clinic Proceedings, 2006
- Update on treatment recommendations from the Third International Workshop on Waldenstrom's MacroglobulinemiaBlood, 2006
- Guidelines on the management of Waldenström macroglobulinaemia*British Journal of Haematology, 2006
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003